Am J Perinatol 2011; 28(6): 485-488
DOI: 10.1055/s-0030-1271210
© Thieme Medical Publishers

Clinical Indications for Abnormal Early Gestational 50-g Glucose Tolerance Testing

Amber Samuel1 , Hyagriv N. Simhan1
  • 1Department of Obstetrics, Gynecology and Reproductive Sciences, Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Further Information

Publication History

Publication Date:
11 January 2011 (online)

ABSTRACT

Providers occasionally screen women thought to be at particularly increased risk of gestational diabetes mellitus (GDM) with a first- or second-trimester (“early”) glucose tolerance test (GTT). We sought to describe how the frequency of abnormal early GTT varies by indication for testing. This is a retrospective cohort study of women receiving prenatal care in our clinic who underwent a 50-g GTT at less than 24 weeks between 2003 and 2006. Three hundred five women received an early GTT. The most common indications for early screening were obesity (53%), family history of diabetes (15%), prior history of GDM (10%), and multifetal gestation (5%). The frequency of abnormal testing in patients with multifetal gestations and a personal history of GDM was higher than in those undergoing early testing because of obesity. The frequency of abnormal early GTT varies by indication for testing. These data may be used in the allocation of health care resources.

REFERENCES

  • 1 Engelgau M M, Herman W H, Smith P J, German R R, Aubert R E. The epidemiology of diabetes and pregnancy in the U.S., 1988.  Diabetes Care. 1995;  18 1029-1033
  • 2 Solomon C G, Willett W C, Carey V J et al.. A prospective study of pregravid determinants of gestational diabetes mellitus.  JAMA. 1997;  278 1078-1083
  • 3 Moore T. Diabetes in pregnancy. In: Creasy R K, Resnik R, eds. Maternal-Fetal Medicine: Principles and Practice. Philadelphia: WB Saunders; 2004: 1023-1058
  • 4 Meyer W J, Carbone J, Gauthier D W, Gottmann D A. Early gestational glucose screening and gestational diabetes.  J Reprod Med. 1996;  41 675-679
  • 5 Carpenter M W, Coustan D R. Criteria for screening tests for gestational diabetes.  Am J Obstet Gynecol. 1982;  144 768-773
  • 6 Metzger B E, Coustan D R. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee.  Diabetes Care. 1998;  21 (Suppl 2) B161-B167

Amber SamuelM.D. 

Department of Obstetrics and Gynecology, Columbia University New York Presbyterian Hospital

622 W. 168th Street, New York, NY 10032

Email: ambersamuelmd@gmail.com

    >